Aspen Neuroscience to Present at 2024 Raymond James Biotech Private Company Showcase July 18
Aspen Neuroscience to Present at 2024 Raymond James Biotech Private Company Showcase July 18
SOURCE Aspen Neuroscience, Inc.SAN DIEGO, July 17, 2024 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical-stage private biotechnology company developing personalized regenerative therapies, announced today that president and CEO Damien McDevitt, PhD, will participate in a virtual fireside chat at the 2024 Raymond James Biotech Private Company Showcase on Thursday, July 18 at 11 a.m. PT / 2 p.m. ET.
生物技術製造業公司Aspen Neuroscience，研發個性化再生療法，公司總裁和首席執行官Damien McDevitt將於美國太平洋時間7月18日週四上午11點/美國東部時間下午2點參加2024年Raymond James生物技術私人公司展示會的虛擬訪談。
About Aspen Neuroscience
Aspen Neuroscience, Inc., headquartered in San Diego, is dedicated to autologous regenerative medicine. The company's patient-derived iPSC platform is used to create personalized therapies, a crucial step in addressing diseases with high unmet medical needs, starting with autologous neuron replacement for Parkinson's disease.
關於Aspen Neuroscience
總部位於聖迭戈的Aspen Neuroscience，專注於自體再生醫學。公司利用患者源性iPSC平台來創建個性化療法，這是解決醫療需求高且未滿足的疾病的關鍵步驟，首先包括帕金森病的自體神經元替代。
Aspen combines cell biology with the latest machine learning and genomic approaches to investigate patient-specific, restorative cell treatments. The company's unwavering commitment to quality is evident in its best-in-class platform to create and optimize pluripotent-derived cell therapies, which includes in-house bioinformatics, manufacturing, and quality control.
Aspen將細胞生物學與最新的機器學習和基因組方法相結合，研究患者特異性的恢復性細胞治療方法。公司對質量的堅定承諾體現在其一流的平台上，用於創建和優化多能幹細胞治療方案，在其中包括內部生物信息學、製造和質量控制。
SOURCE Aspen Neuroscience, Inc.
資料來源Aspen Neuroscience, Inc。
